menu
    • menu

    Company profile for IMU Biosciences

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    IMU is a leading force in expediting the development of cell therapy drugs. Through our state-of-the-art immune analytics platform, we tackle key challenges in the development process, including donor selection, product characterization, and patient stratification and monitoring. Our integrated approach ensures a streamlined and effective development process, facilitating the delivery of cutting-edge therapies to the appropr...
    IMU is a leading force in expediting the development of cell therapy drugs. Through our state-of-the-art immune analytics platform, we tackle key challenges in the development process, including donor selection, product characterization, and patient stratification and monitoring. Our integrated approach ensures a streamlined and effective development process, facilitating the delivery of cutting-edge therapies to the appropriate patients. The IMU platform, known as CytAtlas™, is deployed across various health and disease contexts to propel translational research forward and hasten the drug development timeline.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IMU Biosciencesunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    20 Water Street, Wood Wharf, London E14 5GX
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.imubiosciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/imubiosciences/?originalSubdomain=uk
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IMU Biosciences Appoints Dr Carlos Paya as Non-Executive Director
    IMU Biosciences Appoints Dr Carlos Paya as Non-Executive Director

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191619/0/en/IMU-Biosciences-Appoints-Dr-Carlos-Paya-as-Non-Executive-Director-Strengthening-its-Board-of-Directors.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    IMU Biosciences Adopts Curiox's Pluto for UK Immune Profiling
    IMU Biosciences Adopts Curiox's Pluto for UK Immune Profiling

    15 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/15/3082391/0/en/IMU-Biosciences-Adopts-Curiox-s-Pluto-for-Large-Scale-UK-Immune-Profiling-Initiative.html

    GLOBENEWSWIRE
    15 May 2025
    Share Share
    IMU Biosciences Joins UK Cancer Immunotherapy Consortium
    IMU Biosciences Joins UK Cancer Immunotherapy Consortium

    07 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/07/2958650/0/en/IMU-Biosciences-joins-ground-breaking-UK-research-consortium-investigating-patient-response-to-cancer-immunotherapies.html

    GLOBENEWSWIRE
    07 Oct 2024
    Share Share
    IMU Biosciences Appoints New CEO and CBO
    IMU Biosciences Appoints New CEO and CBO

    17 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/17/2947149/0/en/IMU-Biosciences-expands-leadership-team-with-appointment-of-industry-experts-Dr-John-Baker-as-Chief-Executive-Officer-and-Dr-Jason-Brown-as-Chief-Business-Officer.html

    GLOBENEWSWIRE
    17 Sep 2024
    Share Share
    IMU Biosciences secures £11.5 million in Series A funding
    IMU Biosciences secures £11.5 million in Series A funding

    24 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/24/2814806/0/en/IMU-Biosciences-secures-11-5-million-in-Series-A-funding-to-revolutionise-immune-powered-precision-medicine.html

    GLOBENEWSWIRE
    24 Jan 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search